We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Catalent and UMN Pharma Announce Collaboration

News   Dec 20, 2012

 
Catalent and UMN Pharma Announce Collaboration
 
 
 

RELATED ARTICLES

Gene Therapy Trial a Success in Treating Rare Form of Blindness

News

Results are out from the world’s first gene therapy trial for a genetic cause of blindness, known as choroideremia.

READ MORE

Microtubule Micromorphology: How Microtubules Maintain Cell Structure

News

Understanding how microtubules maintain cell structures may shed light on therapeutic approaches for heart failure and neurodegenerative diseases.

READ MORE

On-demand, Adaptable and Automated Biopharmaceutical Manufacturing

News

Having the ability to produce small batches of drugs makes precision medicine a reality, and accelerates drug development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE